UBS Group’s iShares iBonds Dec 2033 Term Corporate ETF IBDY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$13.8M Buy
534,158
+34,709
+7% +$906K ﹤0.01% 2999
2025
Q4
$13.1M Buy
499,449
+94,577
+23% +$2.48M ﹤0.01% 3015
2025
Q3
$10.6M Buy
404,872
+33,794
+9% +$877K ﹤0.01% 3228
2025
Q2
$9.61M Sell
371,078
-11,648
-3% -$295K ﹤0.01% 3116
2025
Q1
$9.78M Buy
382,726
+38,228
+11% +$967K ﹤0.01% 3064
2024
Q4
$8.65M Buy
344,498
+54,436
+19% +$1.39M ﹤0.01% 3220
2024
Q3
$7.66M Buy
290,062
+58,669
+25% +$1.52M ﹤0.01% 2635
2024
Q2
$5.83M Buy
231,393
+19,646
+9% +$492K ﹤0.01% 2710
2024
Q1
$5.4M Buy
211,747
+168,338
+388% +$4.28M ﹤0.01% 2893
2023
Q4
$1.12M Buy
+43,409
New +$1.06M ﹤0.01% 4400

Other funds holding IBDY

UBS Group's IBDY Position: Q1 2026 in Review

UBS Group increased its iShares iBonds Dec 2033 Term Corporate ETF (IBDY) stake by 6.9% in Q1 2026, buying an estimated $906K and bringing the position to 534,158 shares worth $13.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2999.

UBS Group first reported a position in IBDY in Q4 2023 and has held it in 10 quarters since. 161 funds tracked by Wall St. Rank hold IBDY as of Q1 2026.

  • UBS Group held 534,158 shares of iShares iBonds Dec 2033 Term Corporate ETF worth $13.8M as of Q1 2026.
  • UBS Group bought 34,709 iShares iBonds Dec 2033 Term Corporate ETF shares in Q1 2026, an estimated $906K.
  • iShares iBonds Dec 2033 Term Corporate ETF made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #2999 holding.
  • UBS Group first reported a position in iShares iBonds Dec 2033 Term Corporate ETF in Q4 2023 and has held it in 10 quarters since.
  • 161 funds tracked by Wall St. Rank held iShares iBonds Dec 2033 Term Corporate ETF as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.